SG11201805570WA - Systems and methods for long term transdermal administration - Google Patents

Systems and methods for long term transdermal administration

Info

Publication number
SG11201805570WA
SG11201805570WA SG11201805570WA SG11201805570WA SG11201805570WA SG 11201805570W A SG11201805570W A SG 11201805570WA SG 11201805570W A SG11201805570W A SG 11201805570WA SG 11201805570W A SG11201805570W A SG 11201805570WA SG 11201805570W A SG11201805570W A SG 11201805570WA
Authority
SG
Singapore
Prior art keywords
international
systems
long term
methods
pct
Prior art date
Application number
SG11201805570WA
Other languages
English (en)
Inventor
Eun Lee
Amit Jain
Parminder Singh
Original Assignee
Corium Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corium Int Inc filed Critical Corium Int Inc
Publication of SG11201805570WA publication Critical patent/SG11201805570WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201805570WA 2015-12-30 2016-12-30 Systems and methods for long term transdermal administration SG11201805570WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562273288P 2015-12-30 2015-12-30
US201662367055P 2016-07-26 2016-07-26
PCT/US2016/069558 WO2017117554A1 (en) 2015-12-30 2016-12-30 Systems and methods for long term transdermal administration

Publications (1)

Publication Number Publication Date
SG11201805570WA true SG11201805570WA (en) 2018-07-30

Family

ID=57861282

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805570WA SG11201805570WA (en) 2015-12-30 2016-12-30 Systems and methods for long term transdermal administration

Country Status (12)

Country Link
US (6) US10966936B2 (zh)
EP (1) EP3397250A1 (zh)
JP (1) JP6833855B2 (zh)
KR (1) KR20180127315A (zh)
CN (1) CN108697655B (zh)
AU (2) AU2016381351B2 (zh)
CA (1) CA3010183A1 (zh)
IL (2) IL260290B2 (zh)
MX (1) MX2018008190A (zh)
RU (1) RU2737464C2 (zh)
SG (1) SG11201805570WA (zh)
WO (1) WO2017117554A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
MX2018008190A (es) 2015-12-30 2018-11-12 Corium Int Inc Sistemas y metodos para la administracion transdermica a largo plazo.
JP7174632B2 (ja) 2016-06-23 2022-11-17 コリウム， インコーポレイテッド 親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
WO2018022818A1 (en) * 2016-07-27 2018-02-01 Corium International, Inc. Memantine transdermal delivery systems
KR102406528B1 (ko) 2016-07-27 2022-06-08 코리움, 인크. 아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된 경피성 전달
CN109789134A (zh) * 2016-07-27 2019-05-21 考里安国际公司 与口服递送药代动力学生物等效的透皮递送系统
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US20180303764A1 (en) * 2017-04-19 2018-10-25 Inep Europe Sarl Method for manufacturing a transdermal device
US11052054B2 (en) * 2017-04-19 2021-07-06 Inep Europe Sarl Method for manufacturing a transdermal device
WO2019023499A1 (en) * 2017-07-26 2019-01-31 Corium International, Inc. TRANSDERMAL DELIVERY SYSTEM WITH MICROPOROUS MEMBRANE HAVING SOLVENT FILLED PORES
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CN109432061B (zh) * 2018-11-09 2020-10-30 北京德默高科医药技术有限公司 含有布洛芬或其结构类似物的多层经皮给药系统
RU2705896C1 (ru) * 2019-07-26 2019-11-12 Артем Олегович Бахметьев Трансдермальный пластырь
US11471839B2 (en) * 2019-08-06 2022-10-18 Uop Llc High selectivity membranes for hydrogen sulfide and carbon dioxide removal from natural gas
US20210322365A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use
US20210346207A1 (en) * 2020-05-11 2021-11-11 Marc Sheldon Stevens Four-way stretch therapeutic compress assembly, system, and method
US11596772B2 (en) * 2021-02-07 2023-03-07 Lumen Catheters, LLC Antimicrobial light-emitting percutaneous site dressing

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1880808A (en) 1927-03-28 1932-10-04 Eastman Kodak Co Process of making cellulose esters of carboxylic acids
US1683347A (en) 1927-08-25 1928-09-04 Eastman Kodak Co Process of making chloroform-soluble cellulose acetate
US1698049A (en) 1928-01-18 1929-01-08 Eastman Kodak Co Process of making cellulosic esters containing halogen-substituted fatty-acid groups
US1984147A (en) 1929-10-22 1934-12-11 Eastman Kodak Co Process for the production of cellulose esters and corresponding alkyl esters
US1880560A (en) 1929-12-14 1932-10-04 Eastman Kodak Co Process for the hydrolysis of cellulose acetate
US2129052A (en) 1936-02-04 1938-09-06 Eastman Kodak Co Hydrolyzed cellulose acetate
US3493319A (en) 1967-05-26 1970-02-03 Us Agriculture Esterification of cellulosic textiles with unsaturated long chain fatty acids in the presence of trifluoroacetic anhydride using controlled cellulose-acid-anhydride ratios
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
DE3775830D1 (de) 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US5071656A (en) 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3714140A1 (de) 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US4787888A (en) 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US5123900A (en) * 1991-08-16 1992-06-23 Bertek, Inc. Moisture permeable double disk
US5246705A (en) 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5612411A (en) * 1992-11-18 1997-03-18 Kimberly-Clark Corporation Absorbent phycocolloids and a method for their manufacture
US5489624A (en) * 1992-12-01 1996-02-06 Minnesota Mining And Manufacturing Company Hydrophilic pressure sensitive adhesives
US5567489A (en) * 1993-09-16 1996-10-22 The Dow Chemical Company Multilayer halogen-free barrier film for ostomy and transdermal drug delivery applications
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
EP0799029A1 (en) 1994-12-21 1997-10-08 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6174545B1 (en) * 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
DE60233217D1 (de) 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
US20040024028A1 (en) 2001-08-02 2004-02-05 Burton Steven L. Method for reducing or eliminating smoking
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
IL166687A0 (en) 2002-08-30 2006-01-15 Alza Corp Embossable and writable multilaminate backing construction
CA2515918C (en) 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
EP1807033B1 (en) 2004-10-08 2016-07-20 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
JP2008259629A (ja) 2007-04-11 2008-10-30 Hakujuji Co Ltd 傷保護材
WO2009026135A2 (en) 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
CN100560157C (zh) * 2007-11-13 2009-11-18 重庆市生力医疗设备有限公司 超声波药贴
AU2009257440B2 (en) * 2008-06-13 2014-09-25 ProBiora Health, LLC Use of hydrogen peroxide-producing bacteria for tooth whitening
CN101518599A (zh) * 2009-03-24 2009-09-02 沈阳药科大学 祖师麻提取物缓释贴剂及其制备方法
TWI433904B (zh) 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
US10426739B2 (en) 2011-12-21 2019-10-01 3M Innovative Properties Company Adhesive patch assembly with overlay liner and system and method for making same
KR101239150B1 (ko) 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
US20140276479A1 (en) * 2013-03-14 2014-09-18 Noven Pharmaceuticals, Inc. Transdermal drug delivery system with overlay
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
JP6793648B2 (ja) 2014-12-18 2020-12-02 アイキュア ファーマスーティカル インク． ドネペジルを有効成分として含有する経皮吸収製剤
MX2018008190A (es) * 2015-12-30 2018-11-12 Corium Int Inc Sistemas y metodos para la administracion transdermica a largo plazo.

Also Published As

Publication number Publication date
US10966936B2 (en) 2021-04-06
CN108697655A (zh) 2018-10-23
US20210196650A1 (en) 2021-07-01
KR20180127315A (ko) 2018-11-28
US20240091168A1 (en) 2024-03-21
US20170189348A1 (en) 2017-07-06
JP6833855B2 (ja) 2021-02-24
EP3397250A1 (en) 2018-11-07
IL303255A (en) 2023-07-01
US11648214B2 (en) 2023-05-16
WO2017117554A1 (en) 2017-07-06
AU2016381351B2 (en) 2022-09-29
MX2018008190A (es) 2018-11-12
IL260290A (en) 2018-07-31
CN108697655B (zh) 2021-12-10
RU2737464C2 (ru) 2020-11-30
CA3010183A1 (en) 2017-07-06
US20210023020A1 (en) 2021-01-28
US10835499B2 (en) 2020-11-17
RU2018127642A (ru) 2020-02-03
IL260290B2 (en) 2023-11-01
AU2016381351A1 (en) 2018-07-19
US20170189534A1 (en) 2017-07-06
US11679086B2 (en) 2023-06-20
JP2019504052A (ja) 2019-02-14
IL260290B1 (en) 2023-07-01
AU2022235539A1 (en) 2022-10-13
US20240108587A1 (en) 2024-04-04
RU2018127642A3 (zh) 2020-05-13

Similar Documents

Publication Publication Date Title
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201806863WA (en) Tetracyclic pyridone compounds as antivirals
SG11201810628XA (en) Nasal pharmaceutical compositions with a porous excipient
SG11201804901WA (en) Compounds for the treatment of cancer and inflammatory disease
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201808990QA (en) Compositions for topical application of compounds
SG11201408261UA (en) Syringe
SG11201805072PA (en) Nicotine powder delivery system
SG11201810485SA (en) Substituted carbonucleoside derivatives useful as anticancer agents
SG11201810280YA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201808106YA (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
SG11201810429UA (en) Anti-cd19 antibody formulations
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201810940XA (en) Methods of treating pancreatic cancer
SG11201900043TA (en) Antibody formulations
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901249YA (en) Aza-indazole compounds for use in tendon and/or ligament injuries
SG11201810934TA (en) Microparticles comprising a sulphur-containing compound